InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Quarterly Report and Appendix 4C 31 Jan 2017 11:49AM $0.032 $0.500 risen by 1,462.50%
$7 Unmarketable Parcel Share Sale Facility 19 Jan 2017 3:10PM $0.032 $0.500 risen by 1,462.50%
$7 Appendix 3B 11 Jan 2017 6:06PM $0.037 $0.500 risen by 1,251.35%
$7 Release from escrow 11 Jan 2017 6:01PM $0.037 $0.500 risen by 1,251.35%
$7 Details of Company Address 11 Jan 2017 8:26AM $0.039 $0.500 risen by 1,182.05%
$7 Shareholder Update 9 Jan 2017 8:25AM $0.041 $0.500 risen by 1,119.51%
$7 Zelda to Test Formulations Against Pancreatic Cancer 20 Dec 2016 8:45AM $0.037 $0.500 risen by 1,251.35%
$7 Company Secretary Appointment 16 Dec 2016 2:51PM $0.036 $0.500 risen by 1,288.89%
$7 Sleep Disorder Clinical Trials Update 12 Dec 2016 9:23AM $0.038 $0.500 risen by 1,215.79%
$7 Collaboration Agreement with Telethon Kids Institute 5 Dec 2016 8:34AM $0.031 $0.500 risen by 1,512.90%
$7 Significant Anti-Cancer Effect Observed in Studies 30 Nov 2016 9:31AM $0.023 $0.500 risen by 2,073.91%
$7 Results of Meeting 28 Nov 2016 4:13PM $0.024 $0.500 risen by 1,983.33%
$7 Becoming a substantial holder 25 Nov 2016 6:45PM $0.024 $0.500 risen by 1,983.33%
$7 Change in substantial holding 25 Nov 2016 6:20PM $0.024 $0.500 risen by 1,983.33%
$7 Change in substantial holding 25 Nov 2016 6:18PM $0.024 $0.500 risen by 1,983.33%
$7 Zelda expands its Intellectual Property portfolio 25 Nov 2016 8:25AM $0.025 $0.500 risen by 1,900%
$7 Becoming a substantial holder 23 Nov 2016 6:03PM $0.022 $0.500 risen by 2,172.73%
$7 OpenBriefing Recording with Dr Stewart Washer 23 Nov 2016 4:53PM $0.022 $0.500 risen by 2,172.73%
$7 Investor Presentation 22 Nov 2016 9:16AM n/a $0.500 n/a
$7 Zelda Therapeutics Debuts on ASX 22 Nov 2016 8:27AM n/a $0.500 n/a
$7 Zelda Therapeutics Pty Ltd - 30 June 2016 Accounts 18 Nov 2016 3:39PM n/a $0.500 n/a
$7 Zelda Therapeutics Pty Ltd - 31 December 2015 Accounts 18 Nov 2016 3:39PM n/a $0.500 n/a
$7 Updated Pro-Forma Statement 18 Nov 2016 3:38PM n/a $0.500 n/a
$7 Updated Statement of Commitments 18 Nov 2016 3:37PM n/a $0.500 n/a
$7 Confirmations 18 Nov 2016 3:36PM n/a $0.500 n/a

501 - 525 of 545 results

Page 21 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.